realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL
Clinical trial NCT04981795 · COMPLETED
Trial details
- NCT number
- NCT04981795
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-20
- Primary completion
- 2026-01-23
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.